A 52-year-old woman with acute myocardial infarction (anterior wall) develops cardiogenic shock 6 hours after symptom onset. Despite intra-aortic balloon pump (IABP) insertion and aggressive fluid resuscitation, her cardiac index remains 1.8 L/min/m² (normal >2.2) with pulmonary edema. BP is 88/54 mmHg and urine output is 15 mL/h. Which is the drug of choice for inotropic support in this patient?

Explanation

## Cardiogenic Shock — Inotropic Support Strategy **Key Point:** Dobutamine is the preferred inotrope for cardiogenic shock when cardiac output is low despite adequate preload and afterload reduction. It combines inotropic (β₁) and vasodilatory (β₂) effects, improving contractility while reducing systemic vascular resistance. ### Pathophysiology of Cardiogenic Shock In acute MI with cardiogenic shock: - **Reduced contractility** → low cardiac output - **Elevated LV filling pressures** → pulmonary edema - **Compensatory vasoconstriction** → worsens afterload and myocardial oxygen demand Dobutamine addresses all three mechanisms. ### Inotrope Comparison in Cardiogenic Shock | Agent | β₁ (Inotrope) | β₂ (Vasodilate) | α (Vasoconstrict) | Heart Rate | Arrhythmia Risk | Use in Cardiogenic Shock | | --- | --- | --- | --- | --- | --- | --- | | **Dobutamine** | +++ | ++ | − | ↑ | Moderate | **First-line** | | Milrinone | − | − | − | ↑↑ | Low | Adjunct (phosphodiesterase inhibitor) | | Epinephrine | ++ | ++ | +++ | ↑↑ | High | Rescue only (excessive vasoconstriction) | | Levosimendan | +++ | ++ | − | ↔ | Low | Not available in USA/India | **High-Yield:** Dobutamine's **dual action** (inotrope + vasodilator) is ideal: - Increases contractility → ↑ cardiac output - Reduces afterload → ↓ myocardial O₂ demand - Improves coronary perfusion pressure ### Clinical Pearl **Warning:** Milrinone alone is insufficient for cardiogenic shock because it has **no inotropic effect**—it is a phosphodiesterase-3 inhibitor that causes vasodilation and lusitropy only. It is used as an **adjunct** to dobutamine in refractory cases or in patients with β-blocker use. **Clinical Pearl:** Epinephrine causes excessive vasoconstriction at higher doses, increasing afterload and myocardial oxygen demand—counterproductive in cardiogenic shock. Reserve epinephrine for refractory shock with hypotension unresponsive to dobutamine. **Mnemonic:** **DOPE** for cardiogenic shock inotrope = **D**obutamine (first-line) → **O**ptimize preload/afterload → **P**hosphodiesterase inhibitor (milrinone, adjunct) → **E**pinephrine (rescue) [cite:ACC/AHA 2017 MI Guidelines]